Completed PHASE3 INTERVENTIONAL 2-arm NCT00666263

Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy

A Randomized, Double-Blind, Placebo Controlled, Cross-over Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Multifocal Motor Neuropathy

Sponsor: Baxalta now part of Shire

Conditions Multifocal Motor Neuropathy

Interventions 0.25% human albumin solution (Placebo) Immune Globulin Intravenous (human), 10%

Updated 9 times since 2017 Last updated: Apr 30, 2021 Started: Aug 22, 2008 Primary completion: Aug 11, 2011 Completion: Aug 11, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00666263, this PHASE3 trial focuses on Multifocal Motor Neuropathy and remains completed. Sponsored by Baxalta now part of Shire, it has been updated 9 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jun 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Jun 2021 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Dec 2017 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — Dec 2017 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxalta now part of Shire

Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarhus, Denmark , Baltimore, United States , Boston, United States , Calgary, Canada , Centennial, United States , Columbus, United States , Houston, United States , Kansas City, United States , Kingston, Canada , London, Canada and 7 more locations